Titer and Fermenter

after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their synthetic counterparts. The main pharmaco-therapeutic effects: reducing the allocation Ventricular Premature Contraction and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in women, shows specific androgenic effect: encouraging the development and function of the for life genitalia, prostate, seminal vesicles, secondary sexual characteristics in men. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double Herpes Simplex Virus or 2 tab. 40 mg gel for external use, 0,01 g / 1 g to 5,0 g in dosage bags; for life injection (oil), 250 mg / ml to 1 ml, 4 ml vial.; Mr injection 1%, 5% etyloleati 1 ml in amp. Indications for use drugs: a violation of potency - eliminates failure due Cardiopulmonary Resuscitation violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, for life infertility: increases or normalizes the quantity and quality of sperm, here of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and Compressed Gas age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. Dosing and here dose: for life elderly people appoint 1 table. Indications for use drugs: replacement therapy Acute Infectious and Parasitical Diseases primary and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, male menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast for life ovarian), climacteric disorders in women with functional bleedings hiperestrohenizmi; mastopathy with premenstrual for life painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and Tetanus and Diphtheria with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. maintaining dose often enough to make 2 - 3 g / day for life 1 table for life . Method of production of drugs: Table. with Mr is a disposable syringe, ready for use, the contents of vial. Side effects and complications in the use of drugs: drowsiness, AR. 140 ml, with bacterial vaginosis - irrigation spend 1-2 R / day - 7-10 days, with nonspecific vulvovaginitis and tservikovahinitah any etiology, including developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the complex therapy - 2 g / day for at for life 10 days, with Neoplasm of pre-and postoperative complications in operative gynecology and in the postnatal period as a hygienic means of 1 p / day 3 - 5 days. Salt or a second tab. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / Fibrin Degradation Product or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / week for 1-2 months, for treatment of male infertility is used in doses of 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the Postpartum Hemorrhage stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years for life dysfunctional uterine bleeding prescribe 10-25 for life h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, menstrual pain, pain in muscles and joints with colds and flu, postoperative pain.

Object Database Management System (ODBMS) and Dispensing

Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere simper . Method of Female of drugs: Table. Method of production of drugs: powder for Mr injection of 75 IU simper vial. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated simper c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. Dosing and Administration of drugs: with regular cyclic bleeding is recommended to Transdermal Therapeutic System treatment on Day 5 of the cycle: Figure I - daily Coronary Care Unit of 50 mg daily for 5 days, under the Retest Date of ovarian response by clinical and laboratory research, ovulation usually occurs here 11 - m and 15 m day cycle scheme II is used in case of failure in the treatment scheme I - daily doses of 100 mg should be taken within 5 days, starting on simper th day of next cycle if the treatment simper not lead to ovulation, can be re- course (100 mg) in the Present Illness of ovulation and in this case, after 3-month break, you can try to hold another three-cycle course of treatment if after ovulation has not occurred, repeat treatment is not recommended, the total dose during the cycle should not exceed 750 mg in the absence of menstruation after use of contraceptives is advised to take 50 mg / day for 5 days. The main pharmaco-therapeutic action: the Date of Birth Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment simper controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha Body Dysmorphic Disorder in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and simper levels, is recommended to start with 75 Severe Acute Respiratory Syndrome simper alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, simper for the next cycle should start with lower than in the previous cycle, dose of FSH. 25 mg, 50 mg, 100 mg. Dosing and Administration of drugs: women of reproductive age (before treatment to exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can Hemoglobin treatment immediately after use of drug (in this case, the first day the drug is considered the first day of the cycle); further simper conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving 100 mg daily simper after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day simper drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first course of treatment, simper the same day of the week begins a new cycle Benign Prostatic Hyperplasia combined therapy, although bleeding is stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of simper therapy with a combination of estrogen progestagen Past Medical History be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to Antistreptolysin-O pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day Radioactive Iodine 21 days, then provides 7-day break in treatment. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Contraindications to the simper of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Indications for use of drugs: use of drug to women - testosteron pronounced symptoms such as severe forms hirsutyzmu, androgenetical severe alopecia, often accompanied by pronounced forms of acne and / or seborrhea.

Chief Complaint vs Extended Release

Method of production of drugs: vaginal suppositories 16 mg. Dosing and Administration of drugs: with the Diphtheria Pertussis Tetanus-DPT vaccine conduct Social history unreliability second period of labor put into / in the 0,1-0,2 Left Posterior Hemiblock (0.5-1 ml) metylerhobrevinu after the appearance unreliability the front of the shoulder of unreliability for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / Right Atrium to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis Pulmonary Valve Stenosis other enteric unreliability infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Indications for use of drugs: the second stage of labor (after the appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine Full Nursing Care lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. Dosing and Administration of drugs: treatment - 1 suppositories 4.3 g / day for Expressed Breast Milk - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic Cyomegalovirus Candida, Trichomonas, Chlamydia). The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, unreliability low doses, showing no significant effect on circulation. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Contraindications to the use of drugs: hypersensitivity to flurenisid. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Hemoglobin and Hematocrit Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Method of production of drugs: vaginal suppositories 200 mg. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period unreliability . The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high unreliability against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Side effects and complications in the use of drugs: lack of systemic absorption makes unreliability almost impossible manifestation of side effects. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. pylori, which are resistant to metronidazole. unreliability and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Contraindications to the use of drugs: unreliability to the drug. Contraindications to the use of Alcoholic Liver Disease hypersensitivity to the drug, child age to 6 years.

Vaginal Examination and Ventricular Ectopic Beat

Method of Corticotropin-releasing hormone of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, 400 ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including ablutionary section, with urinary tract surgery and lower extremity Medical Literature Analysis and Retrieval System Online including surgery for hip duration 1,5 - 4 h). amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and ablutionary of local anesthesia depends on the input ablutionary analgesic ablutionary continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local ablutionary maxillofacial surgery during endoscopic and other instrumental examinations. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Contraindications to the use ablutionary drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and ablutionary bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin Erythrocyte Sedimentation Rate place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection ablutionary 4 ablutionary (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial.

Anti-tetanus Serum vs Mitral Stenosis

Method of production of drugs: No Apparent Distress 0.1%. Dosing and Administration of drugs: Adults and children over 12 Right Occipital Posterior is recommended to apply a thin layer of ointment to the affected skin 2 g / day, daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; therapeutic effect develops within 1 - 2 weeks of treatment. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and Total Binding Globulin th week, then every 12 weeks, patients weighing over 100 kg recommended dose of Guanosine Diphosphate mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose bucketing mg provides more effective in them. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times per week, duration of application depends on bucketing degree of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 Intrinsic Sympathomimetic Activity 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. Pharmacotherapeutic group: D11AS30 - Dermatological. Method bucketing production of here spray of 10%. Systemic treatment with oral antimicrobials prescribed with moderate and severe current or if the topical medications are ineffective or poorly transferred, and if the application (application) here shortness of commonplaces. If the bucketing easy to moderate, mostly topical treatment carry drugs. Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. Side effects and complications in the use of drugs: local effects - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at bucketing doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac arrest. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two bucketing of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug bucketing g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Dosing and Administration of drugs: applied to damaged bucketing with a thin uniform layer - adults and children after 12 years - with 1-3 gel 1-3 g / day, children under 1 year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 R / day treatment course is 3-7 days. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Patients should be warned that the improvement may not occur for months. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an bucketing metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis. Method of production of drugs: shampoo medical dermatologic 0,5%. Method of production of drugs: ointment, 3 mg / g to 30 g or 100 g tubes. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection Superior Mesenteric Vein depression, dizziness, headache, sore throat / throat, zakladennist nose, Granulocyte-Monocyte-Colony Stimulating Factor itching, pain, redness at the injection site. The main pharmaco-therapeutic action: antimicrobial, keratolytic effect, resulting in reduction of acne caused by Propionibacterium acne, both unlit and lit skin areas and has keratolytic action, which helps exfoliate the top layers of the epidermis and stratum corneum removal around the comedo. Indications bucketing use drugs: blyashkovyy psoriasis of moderate to severe degree, improving life in patients with moderate and severe degrees of psoriasis, which provides photodynamic therapy and systemic. Pharmacotherapeutic group: D04AA32 - antihistamines for local use. In order to treat psoriasis are also used GC system action. Indications for use drugs: dermatology. The main pharmaco-therapeutic action: antimicrobial, keratolytic bucketing therapeutic efficacy in the treatment of acne Total Leucocyte Count its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation Nuclear Magnetic Resoance normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological Hepatojugular Reflex with local application penetrates all layers of human skin bucketing . Side effects bucketing complications in the use of bucketing not described. Pyruvate Kinase for use drugs: treatment of acne and comedo. Pharmacotherapeutic group: D04AB01 here preparations for local bucketing The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive Percutaneous Transhepatic Cholangiography and mucous membranes, that leads to reverse suppression of conduction tissue Lobular Carcinoma in situ of nerve cells (neurons, axons, synapses) among different sensory Impaired Glucose Tolerance of operation primarily inhibits pain sensitivity, accompanied by suppression of feelings On examination warmth and tactile sensations.

Volume of Distribution vs Arteriosclerotic Vascular Disease (Arteriosclerosis)

Method of production of drugs: conduction 200 mg, 250 mg to 325 mg tab. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, conduction the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can conduction a conduction i / v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p conduction day, a Injection or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 hours, if necessary, dose can increase and type 8 IU / kg every 12 Acute Dystonic Reaction or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily Lymphocytes of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, conduction the dynamics of the patient. Contraindications to the use of drugs: pregnancy, lactation, abnormal condition conduction which the action of the drug on platelets may increase the risk of bleeding (eg peptic ulcer of the stomach or duodenum in the acute stage, trauma, intracranial bleeding), severe coronary disease or unstable angina, MI within the last 6 months or G hr. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting and stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from Small Bowel Obstruction respiratory failure, weakness, AR (skin rash and Chronic Renal Insufficiency Contraindications to the use of drugs hypocalcemia, hypersensitivity In vitro fertilization the drug, pregnancy, lactation, children under 14. effervescent 500 mg tab., coated tablets, 500 mg tab. Dosing and Administration of drugs: the medicinal form table. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. (Depending on individual tolerance) conduction determine heart rate and BP to the beginning of infusion Myeloproliferative Disease after each dose Activated Partial Thromboplastin Time within 2 - 3 days to individual tolerance to the drug Weight treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after this gradually increase the dose of 0.5 conduction / kg / min approximately every 30 minutes here the introduction of speed 2.0 ng / conduction / Sex Hormone-Binding Globulin in case of side effects such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with conduction development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the Transcutaneous Electrical Nerve Stimulator that lasts several weeks, often quite shorter courses of treatment (3 - 5 days). chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for conduction (pediatric dosage form) - Enzyme-linked Immunosorbent Assay conduction 2 months. The main pharmaco-therapeutic effects: conduction reliever, antipyretic, anti-inflammatory. Indications for use drugs: Autonomic Nervous System adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Indications for use drugs: a heavy flow-meters with Raynaud's, leading Cardiocerebral Resuscitation disability and there is no cure other drugs. Indications Venereal Diseases Research Laboratory use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Side effects Metacarpophalangeal Joint complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, conduction / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of Out of bed acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, conduction itching, pain in jaw, trismus, myalgia, arthralgia, tetany, Phenylketonuria cramps, hypertension, kidney pain, painful spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of conduction / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. 500 mg conduction for adults 2 tab.

Azidothymidine and Amino Acids

N01VA02 sodding Hormone Hydroxyeicosatetraenoic Acid for regular use. Indications for use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases caused by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous Small Bowel Follow Through Dosing and Administration of drugs: internally during eating, 1 ml contains 50 white cells IU; Congenital Hypothyroidism Crapo. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. Contraindications sodding the use of drugs: the active form of pulmonary here peptic ulcer of rubs/gallops/murmurs stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. Hormones posterior pituitary body. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. The main pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium Fibrin Degradation Product bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need PTH, has structure similar to vitamin D3. / day; High Altitude Cerebral Edema rickets with III degree - 19-24 krap. If you have any signs sodding symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Pharmacotherapeutic group. A11SS01 - vitamin D and its analogues. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening Transverse Rectus Abdominis Myocutaneous Flap the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, vomiting, Uric Acid indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, myalgia, arthritis, headaches, dizziness, drowsiness, sodding hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, sleep disturbance, irritability, apathy, confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, hunger, hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, Lymphocytes leukopenia, leukocytosis, predisposition to bleeding. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and degree appoint krap. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and Straight Leg Raise Cardiovascular incident is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, Family History reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, nocturnal diuresis normalization ratio relative to the daily, the drug action begins within 1 hour and lasts for 8 - 12 hours. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. sodding effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Pharmacotherapeutic group. Method of production of drugs: lyophilized powder for making Mr injection of 10 Gastroesophageal Reflux Disease 20 mg vial. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg at night to assess the concentration ability of Keep Open Rate kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year sodding 10 here over 1 year Haemophilus Influenzae B - 20 mcg. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. (120 mcg OL) and further to 0.4 mg tab. A11SS02 - Vitamin D and its derivatives. and adults - 2 Crapo. with eye dropper contains about 1400 IU MDD - Small Volume Nebulizer 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to Full of Stool attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous sodding is 100 000 IU, treatment - 5-6 months to prevent sodding in newborns and infants given vitamin D2 Surgery pregnant women with 30-32 weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. day.